These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9204260)

  • 21. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
    Marinova-Mutafchieva L; Williams RO; Mauri C; Mason LJ; Walmsley MJ; Taylor PC; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Mar; 43(3):638-44. PubMed ID: 10728758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour necrosis factor-alpha as a new therapeutic target for rheumatoid arthritis: an update.
    Giasuddin AS; Hoque ME; Ahmed ZU
    Bangladesh Med Res Counc Bull; 2005 Dec; 31(3):88-94. PubMed ID: 17549869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Destruction of articular cartilage].
    Koike T
    Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
    Miossec P
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammation and joint destruction during rheumatoid polyarthritis: what relation?].
    Combe B
    Presse Med; 1998 Mar; 27(10):481-3. PubMed ID: 9767983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
    Bondeson J; Maini RN
    Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TNF-alpha transgenic mouse model of inflammatory arthritis.
    Li P; Schwarz EM
    Springer Semin Immunopathol; 2003 Aug; 25(1):19-33. PubMed ID: 12904889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
    Yamaguchi Y; Yamamoto K
    Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis.
    Müller-Ladner U; Pap T; Gay RE; Neidhart M; Gay S
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):102-10. PubMed ID: 16932639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
    Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis.
    Tarner IH; Neumann E; Gay S; Fathman CG; Müller-Ladner U
    Autoimmun Rev; 2006 Feb; 5(2):148-52. PubMed ID: 16431349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New treatments of rheumatoid arthritis for future use].
    Cantagrel A; Mazières B
    Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):45S-52S. PubMed ID: 8162008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for rheumatoid arthritis.
    Burstein H
    Curr Opin Mol Ther; 2001 Aug; 3(4):362-74. PubMed ID: 11525560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
    Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
    Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy in rheumatic diseases.
    Vervoordeldonk MJ; Tak PP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for arthritis.
    Robbins PD; Evans CH; Chernajovsky Y
    Gene Ther; 2003 May; 10(10):902-11. PubMed ID: 12732875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical loading, cartilage degradation, and arthritis.
    Sun HB
    Ann N Y Acad Sci; 2010 Nov; 1211():37-50. PubMed ID: 21062294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neutrophil in rheumatoid arthritis.
    Pillinger MH; Abramson SB
    Rheum Dis Clin North Am; 1995 Aug; 21(3):691-714. PubMed ID: 8619095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.